Jiping Sun

Xi'an, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Silencing of USP22 promotes FGF11 degradation to attenuates renal fibrosis in diabetic kidney disease.

Silencing of USP22 promotes FGF11 degradation to attenuates renal fibrosis in diabetic kidney disease.

Journal: Renal failure

Published: June 10, 2026

Anti-CD20 Therapies and Antinephrin Autoantibodies in IgA Nephropathy With Minimal Change Disease.

Anti-CD20 Therapies and Antinephrin Autoantibodies in IgA Nephropathy With Minimal Change Disease.

Journal: Kidney international reports

Published: January 08, 2026

Preliminary analysis of short-term real-world outcomes of telitacicept in high-risk IgA nephropathy.

Preliminary analysis of short-term real-world outcomes of telitacicept in high-risk IgA nephropathy.

Journal: Frontiers in medicine

Published: September 03, 2025

Observation of the therapeutic effect of finerenone, a novel non-steroidal mineralocorticoid receptor antagonist, in patients with non-diabetic CKD.

Observation of the therapeutic effect of finerenone, a novel non-steroidal mineralocorticoid receptor antagonist, in patients with non-diabetic CKD.

Journal: Renal failure

Published: August 13, 2025

Deciphering N-Glycosylation Dynamics of Serum Monoclonal Immunoglobulins in Multiple Myeloma via EThcD-sceHCD-MS/MS.

Deciphering N-Glycosylation Dynamics of Serum Monoclonal Immunoglobulins in Multiple Myeloma via EThcD-sceHCD-MS/MS.

Journal: Journal of proteome research

Published: April 09, 2025

Additive Obinutuzumab Achieves High Remission Rates in Rituximab-Refractory Membranous Nephropathy.

Additive Obinutuzumab Achieves High Remission Rates in Rituximab-Refractory Membranous Nephropathy.

Journal: American journal of nephrology

Published: October 17, 2024

Efficacy and safety of belimumab in refractory and newly diagnosed active lupus nephritis patients: a real-world observational study.

Efficacy and safety of belimumab in refractory and newly diagnosed active lupus nephritis patients: a real-world observational study.

Journal: Clinical kidney journal

Published: September 16, 2024

Obinutuzumab is effective for the treatment of frequently-relapsing/steroid-dependent minimal change disease in adults.

Obinutuzumab is effective for the treatment of frequently-relapsing/steroid-dependent minimal change disease in adults.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: September 18, 2023

Serum Phosphorus Might Be a Predictor of Kidney Disease Progression in IgA Nephropathy.

Serum Phosphorus Might Be a Predictor of Kidney Disease Progression in IgA Nephropathy.

Journal: Kidney & blood pressure research

Published: July 11, 2023

Analysis of the Expression of Exostosins and Clinicopathological Features in Membranous Lupus Nephritis in a Chinese Cohort.

Analysis of the Expression of Exostosins and Clinicopathological Features in Membranous Lupus Nephritis in a Chinese Cohort.

Journal: Kidney international reports

Published: May 03, 2022

Epidemiological characteristics and pathological changes of primary glomerular diseases.

Epidemiological characteristics and pathological changes of primary glomerular diseases.

Journal: PloS one

Published: January 18, 2022

Compositional Alterations of Gut Microbiota in Patients with Diabetic Kidney Disease and Type 2 Diabetes Mellitus.

Compositional Alterations of Gut Microbiota in Patients with Diabetic Kidney Disease and Type 2 Diabetes Mellitus.

Journal: Diabetes, metabolic syndrome and obesity : targets and therapy

Published: November 04, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026